NEO BRONCHOPHINE SYRUP; guaifenesin, diphenhydramine, respiratory tract agents .
ACTIVE-INGREDIENT OF NEO BRONCHOPHINE SYRUP
each 100 ml contains : guaiphenesin 1 g . – diphenhydramine hydrochloride 100 mg . – oxeladin citrate 200 mg .
INDICATION OF NEO BRONCHOPHINE SYRUP
acute and chronic bronchitis , asthmatic bronchitis and common cold associated with cough .
DOSAGE OF NEO BRONCHOPHINE SYRUP
Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet
Ask your pharmacist or doctor for help if you do not understand the instructions on the box .
The recommended dose is : –
adults : 1 tablespoonful 3-4 times daily . – children over 6 years : 1/2 – 1 teaspoonful 3-4 times daily .
OVER-DOSAGE OF NEO BRONCHOPHINE SYRUP
overdosage treatment : if the overdose is recently consumed , the stomach should be emptied , emetics may be tried if the patient as alert and there are no symptoms of toxicity. Activated charcoal can be given . Convulsions can be controlled with diazepam then complete treatment as supportive and symptomatic to control respiration . hyperpyrexia and reduced blood pressure .
CONTRA-INDICATION OF NEO BRONCHOPHINE SYRUP
hypersensitivity to any of the components of the drug . – patients with acute porphyria . – premature infants or neonates . – neo-bronchophane is contraindicated in children less than 2 years , and not to be taken with children less than 6 years without medical supervision .
STORAGE OF NEO BRONCHOPHINE SYRUP
store at a temperature not exceeding 30 ° C .
PACK OF NEO BRONCHOPHINE SYRUP
CARTON BOX CONTAINING A brown glass bottle ( type NP) OF 125 ml with pilfer proof aluminium cap and insert leaflet .
NEO BRONCHOPHINE SYRUP MANUFACTURED BY
EGYPTIAN INT . PHARMACEUTICAL INDUSTRIES CO. E.I.P.CO. TENTH OF RAMADAN CITY , AREA B1 P.O.BOX 149 TENTH,EGYPT